On December 9, the first Berlin Science Slam "Cell and Gene Therapy Meets Bio Revolution" took place, a joint initiative of SPARK-BIH, Max Delbrück Center for Molecular Medicine (MDC) and Young Bayer. During the online event with a total of more than 50 participants, three young scientists from Charité, MDC and Bayer gave a high-level non-confidential pitch presentation on their projects in the field of cell and gene therapy. Among them was PD. Dr. Antonia Busse from the Charité with her SPARK-BIH funded project on a new innovative TCR T cell immunotherapy against aggressive B cell lymphomas.
Furthermore, participants had the opportunity to network and exchange ideas in separate online breakout rooms on topics such as gene therapy, gene editing and immuno-oncology. The event marks the start of a planned series to further strengthen the exchange and collaboration of young translational scientists in the capital region.
